Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3NIH 2

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3

Conditions

Leukemia, Myeloid, Acute 67Leukemia 28Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Lymphoma 20Lymphoma, Follicular 14Congenital Abnormalities 14Lymphoma, Non-Hodgkin 13Recurrence 12Lymphoma, Large B-Cell, Diffuse 12Leukemia, Monocytic, Acute 12Myelodysplastic Syndromes 11Leukemia, Lymphocytic, Chronic, B-Cell 9Leukemia, Erythroblastic, Acute 9Prostatic Neoplasms 8Lymphoma, Large-Cell, Immunoblastic 8Leukemia, Myelomonocytic, Acute 8Leukemia, Megakaryoblastic, Acute 8Leukemia, Biphenotypic, Acute 8Lymphoma, Mantle-Cell 7Hodgkin Disease 5Burkitt Lymphoma 5Blast Crisis 5Lymphoma, B-Cell, Marginal Zone 3Leukemia, Promyelocytic, Acute 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Sarcoma, Myeloid 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Neoplasms 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2

Interventions

Arsenic Trioxide 21Tretinoin 20Cytarabine 12Cyclophosphamide 11Busulfan 10Methotrexate 9Idarubicin 9Filgrastim 8fludarabine phosphate 7Peripheral Blood Stem Cell Transplantation 6Tacrolimus 5Gemtuzumab 5Etoposide 5Radiotherapy 4Clofarabine 4Antilymphocyte Serum 4Topotecan 3Mycophenolic Acid 3Mitoxantrone 3Mercaptopurine 3Daunorubicin 3venetoclax 2lintuzumab 2Whole-Body Irradiation 2Thiotepa 2Sorafenib 2Granulocyte Colony-Stimulating Factor 2Cyclosporins 2Cyclosporine 2Carboplatin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Leukemia, Promyelocytic, Acute × Mitoxantrone × Clear all
NCT02688140 2026-05-29

TUD-APOLLO-064

Technische Universität Dresden

Phase 3 Completed
133 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

NCT00408278 2014-10-28

Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005)

PETHEMA Foundation

Phase 4 Completed
300 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

NCT00180128 2011-07-11

AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia

Technische Universität Dresden

Phase 4 Unknown
80 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡